Molecular classification of hormone‐sensitive and castration‐resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens

BACKGROUND: Despite the rapidly evolving therapeutic landscape, immunotherapy has demonstrated limited activity in prostate cancer. A greater understanding of the molecular landscape, particularly the expression of immune‐related pathways, will inform future immunotherapeutic strategies. Consensus n...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuen, Kobe C., Tran, Ben, Anton, Angelyn, Hamidi, Habib, Costello, Anthony J., Corcoran, Niall M., Lawrentschuk, Nathan, Rainey, Natalie, Semira, Marie C. G., Gibbs, Peter, Mariathasan, Sanjeev, Sandhu, Shahneen, Kadel, Edward E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321082/
https://www.ncbi.nlm.nih.gov/pubmed/35435276
http://dx.doi.org/10.1002/pros.24346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321082/
https://www.ncbi.nlm.nih.gov/pubmed/35435276
http://dx.doi.org/10.1002/pros.24346

Ejemplares similares